Atsuhiro Araki Selected Research

Residual Neoplasm

10/2014

A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsuhiro Araki Research Topics

Disease

4	Colorectal Neoplasms (Colorectal Cancer) 10/2014 - 09/2003
3	Neoplasms (Cancer) 10/2014 - 10/2004
1	Residual Neoplasm 10/2014
1	Adenocarcinoma 01/2014
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Colonic Neoplasms (Colon Cancer) 10/2004

Drug/Important Bio-Agent (IBA)

2	doxifluridineIBA 08/2013 - 03/2010
2	Irinotecan (Camptosar)FDA LinkGeneric 08/2013 - 03/2010
1	VaccinesIBA 10/2014
1	Cancer VaccinesIBA 10/2014
1	Interleukin-18 (Interleukin 18)IBA 10/2014
1	Colloids (Colloid)IBA 01/2014
1	MucinsIBA 01/2014
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 08/2013
1	Interleukin-15 (Interleukin 15)IBA 10/2004
1	Matrix Metalloproteinases (MMPs)IBA 09/2003

Therapy/Procedure

1	Radiotherapy 01/2014
1	Drug Therapy (Chemotherapy) 03/2010